Health Legislation

The executive Decree No 22-401 of 26 Rabie Ethani 1444 establishes the composition, organization and operation of the National Health Observatory. It was published in the Official Journal of 24 November 2022 (pages 7 -10).

This Decree regulates the organization and operation of a public establishment called the National Institute of Public Health. This document is published as a part of the Official Journal and the Decree is located on page 31 of the file.

The decree regulates the establishment, organization and functioning of the National Public Health Institute of Burundi.

The Regulation sets up rules in the registration of drugs and related products manufactured, imported, exported, advertised, sold, distributed or used in Nigeria.  

Specifications for essential medicines supplies.

These Regulations provide rules on the registration and access to the market to medicine; licensing requirements for pharmaceutical operations, manufacturers, wholesalers and dispensaries; as well as on record-keeping, import of medicines, and clinical trials, etc.

The Ordinance creates a national public scientific and technological establishment called the "Institut national de Santé Publique" (National Institute of Public Health). The mission of the Institut National de Santé Publique is to set up a health monitoring and epidemiological surveillance system, and to promote research into health policies and systems.

The Decree rules on the organization and operating procedures of the National Institute of Public Health created by Ordinance n°2019-011/P-RM of March 27, 2019 creating the National Institute of Public Health.

This Law establishes the rules for the efficient and safe production, distribution, use and availability, as well as quality assurance of medicines, vaccines, biological and health products for citizens.

These are the guidelines for the registration, renewal, change in characteristics and extension in range of both imported and locally manufactured registered pharmaceutical products.

This document provides guidelines on the supply of essential medicines in the Democratic Republic of Congo.

This Ministerial decree regulates the trade of pharmaceutical products in the Democratic Republic of the Congo.

This regulation is issued to implement the Food Medicine and Health Care Administration and Control Proclamation No 661/2009. and covers among other aspects of food safety and quality which includes manufacturing, storage and transportation among other aspects; sale of alcohol; medicine administration and control which includes manufacturing, registration, storage, transportation, importation ad clinical trials among others; traditional and complementary medicine administration and control; post-marketing surveillance; control of tobacco products and places prohibited for smoking among other aspects.  

The Act regulates the quality and safety of medicines and related products and connected matters.

These Regulations govern the issuance of licenses for the importation, exportation, manufacture, distribution, and retail of drugs, etc.

This Act provides for the registration, regulation of the sale, distribution, importation, exportation, manufacture and dispensing of medicines and related substances, and matters incidental thereto.

The law creates a public administrative establishment, with legal personality and financial autonomy, called the Centre national de lutte contre le cancer (National Cancer Center).

The Diploma approves the Medicines Registration Manual. The purpose of the Manual is to (a) Standardize the procedures and activities relating to the registration of medicines; (b) Clarify the doubts that professionals have encountered when interpreting the Registration Regulations; (c) Support professionals in the field in carrying out their daily activities in a standardized way; (d) Support applicants in complying with registration and post-registration procedures; (e) to make the registration process an optimized and increasingly swift process. 

The Decree sets out the conditions for manufacturing and importing contraceptive products into Burkina Faso.

This Act amends the Medicines and Related Substances Control Act, 2003, so as to amend and delete certain definitions; provides for a period within which the Council must be appointed; provides for the appointment of chairpersons of committees established by the Council; amends provisions relating to the classification of medicines and other substances as scheduled substances; amends provisions relating to the manufacturing, packing and selling of specified Schedule 3 and specified Schedule 4 substances; deletes references to generic substitutions; substitutes references to Schedule 1, Schedule 2, Schedule 3 or Schedule 4 medicines by references to Schedule 1, Schedule 2, Schedule 3 or Schedule 4 substances; inserts provisions relating to the registration of premises engaged in the manufacturing of medicines; amends provisions relating to offences and penalties; amends provisions relating to the destruction of forfeited medicines, scheduled substances or other things; provides for the making of regulations in relation to medicines; amends provisions relating to the exclusion of medicines from the operation of the Act; amends the transitional provisions; amends provisions relating to the repeal and amendment of certain laws; and provides for matters incidental thereto.